Under construction – not a live service
Sign in
Taking people in ArgentinaNo phase

Registry following adults with lupus in Argentina over time

Records real-world care and outcomes of adults with systemic lupus erythematosus in Argentina.

Plain-language title generated from the registry record
Registry title: Argentinian Prospective Registry of Patients With Lupus

Key facts

Where
La Plata, ArgentinaSee the site

Where in Argentina

  • Lucila GarciaLa Plata, ArgentinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Sociedad Argentina de Reumatologia
Trial code
NCT05470569
Record updated
22 July 2022
Original description
In Latin America, information about patients with systemic lupus erythematosus (SLE) is limited. Multicenter studies are needed to obtain "real world data '' and to carry out longer follow-ups. The purpose of this project is to design a cohort of Argentinian patients with SLE to describe "our real setting" and to identify possible limitations in access to specialized consultations and treatments.Read full original descriptionShow less

Prospective Registry of Patients With Systemic Lupus Erythematosus of the Argentinian Society of Rheumatology

In Latin America, information about patients with systemic lupus erythematosus (SLE) is limited. Multicenter studies are needed to obtain "real world data '' and to carry out longer follow-ups. The purpose of this project is to design a cohort of Argentinian patients with SLE to describe "our real setting" and to identify possible limitations in access to specialized consultations and treatments.

Inclusion: Patients ≥ 18 years of age; Classified as SLE (according to the 1982/1997 American College of Rheumatology criteria and/or Systemic Lupus International Collaborating Clinics criteria for SLE); Less than 5 years from meeting SLE criteria; Informed consent signature.

Exclusion: Diagnosis of other systemic autoimmune diseases or overlap syndromes; Patients who have been transferred to other centers.

ClinicalTrials.gov NCT05470569